Advertisement

European Journal of Dermatology

, Volume 24, Issue 2, pp 274–275 | Cite as

Idiopathic hypereosinophilic syndrome with multiple organ infarction: improvement of the skin condition masking the course of disease

  • Hannes Trattner
  • Friedrich Breier
  • Andreas Steiner
  • Marlies Wruhs
  • Robert Feldmann
Correspondence
  • 31 Downloads

Keywords

Allergy Clin Immunol Telmisartan Tamsulosin Bullous Pemphigoid Hypereosinophilic Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975; 54: 1–27.CrossRefGoogle Scholar
  2. 2.
    Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012; 130: 607–612.PubMedCrossRefGoogle Scholar
  3. 3.
    Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009; 124: 1319–1325.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008; 358: 1215–1228.PubMedCrossRefGoogle Scholar
  5. 5.
    Simon HU, Klion A. Therapeutic Approaches to Patients with Hypereosinophilic Syndromes. Semin Hematol 2012; 49: 160–170.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Park SM, Park JW, Kim SM, et al. A case of hypereosinophilic syndrome presenting with multiorgan infarctions associated with disseminated intravascular coagulation. Allergy Asthma Immunol Res 2012; 4: 161–164.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006; 117: 1292–1302.PubMedCrossRefGoogle Scholar
  8. 8.
    Helbig G, Wisniewska-Piaty K, Francuz T, Dziaczkowska-Suszek J, Kyrcz-Krzemien S. Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients. Leuk Lymphoma 2013; 54: 807–811.PubMedCrossRefGoogle Scholar
  9. 9.
    Podjasek JC, Butterfield JH. Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature. Leuk Res 2013; 37: 392–395.PubMedCrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2014

Authors and Affiliations

  • Hannes Trattner
    • 1
  • Friedrich Breier
    • 2
  • Andreas Steiner
    • 2
  • Marlies Wruhs
    • 2
  • Robert Feldmann
    • 2
  1. 1.Department of Gastroenterology and HepatologyMedical University of ViennaViennaAustria
  2. 2.Department of DermatologyHietzing Municipal HospitalViennaAustria

Personalised recommendations